文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

腹泻型肠易激综合征患者空肠出现肥大细胞活化和增生。

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

作者信息

Guilarte Mar, Santos Javier, de Torres Inés, Alonso Carmen, Vicario María, Ramos Laura, Martínez Cristina, Casellas Francesc, Saperas Esteban, Malagelada Juan Ramón

机构信息

Department of Medicine, Hospital Universitari General Vall d'Hebron, 08035 Barcelona, Spain.

出版信息

Gut. 2007 Feb;56(2):203-9. doi: 10.1136/gut.2006.100594. Epub 2006 Sep 27.


DOI:10.1136/gut.2006.100594
PMID:17005763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1856785/
Abstract

BACKGROUND: Increased numbers of mast cells and mast cell activation in distal gut segments are associated with symptom onset and severity in irritable bowel syndrome (IBS). Although upper gut symptoms are common, mast cells have not been thoroughly evaluated in proximal gut in IBS patients. METHODS: Jejunal biopsies obtained by Watson's capsule, aspiration of intestinal fluid and one blood sample were obtained in 20 diarrhoea-predominant patients with IBS (D-IBS) and 14 healthy volunteers (H). Psychological stress (Holmes-Rahe Scale) and depression (Beck's Depression Inventory) were evaluated at baseline and food and respiratory allergy excluded. Biopsies were processed for H&E staining and microscopic inflammation assessed by counting intraepithelial lymphocytes. Mast cells in lamina propria were counted by immunohistochemistry with CD117 (c-kit). Tryptase concentration was measured in intestinal fluid and serum. RESULTS: D-IBS patients showed higher psychological stress than healthy volunteers (D-IBS: 203 (SD 114) v H: 112 (SD 99); p = 0.019). Immunohistochemical staining of jejunal mucosa revealed mild increase in intraepithelial CD3+ cells in D-IBS patients (D-IBS: 15.3 (SD 5.5; 95% CI 12.7 to 17.9) v H: 10.3 (SD 3.9; 95% CI 8.0 to 12.5); p = 0.006). Moreover, D-IBS patients showed marked increase in mast cells numbers (D-IBS: 34 (SD 9.3); H: 15.3 (SD 4.4) mast cells/hpf; p<0.001) and higher tryptase concentration in jejunal fluid (D-IBS: 0.45 (SD 0.38); H: 0.09 (SD 0.10) microg/l; p = 0.005). Upper gut symptoms were not associated with gender, mast cell counts, jejunal tryptase or basal stress. CONCLUSION: This jejunal mucosal inflammatory profile may help identify diarrhoea-predominant IBS, a stress-related disorder.

摘要

背景:远端肠道段肥大细胞数量增加和肥大细胞活化与肠易激综合征(IBS)的症状发作及严重程度相关。尽管上消化道症状很常见,但IBS患者近端肠道中的肥大细胞尚未得到充分评估。 方法:对20例腹泻型肠易激综合征(D-IBS)患者和14名健康志愿者(H)进行了经沃森胶囊获取空肠活检、抽取肠液及采集一份血样。在基线时评估心理应激(霍尔姆斯-拉赫量表)和抑郁(贝克抑郁量表),并排除食物和呼吸道过敏。对活检组织进行苏木精-伊红染色,通过计数上皮内淋巴细胞评估微观炎症。用CD117(c-kit)免疫组化法计数固有层中的肥大细胞。测量肠液和血清中的类胰蛋白酶浓度。 结果:D-IBS患者的心理应激高于健康志愿者(D-IBS:203(标准差114)对H:112(标准差99);p = 0.019)。空肠黏膜免疫组化染色显示D-IBS患者上皮内CD3 +细胞轻度增加(D-IBS:15.3(标准差5.5;95%置信区间12.7至17.9)对H:10.3(标准差3.9;95%置信区间8.0至12.5);p = 0.006)。此外,D-IBS患者的肥大细胞数量显著增加(D-IBS:34(标准差9.3);H:15.3(标准差4.4)个肥大细胞/高倍视野;p<0.001),空肠液中的类胰蛋白酶浓度更高(D-IBS:0.45(标准差0.38);H:0.09(标准差0.10)μg/l;p = 0.005)。上消化道症状与性别、肥大细胞计数、空肠类胰蛋白酶或基础应激无关。 结论:这种空肠黏膜炎症特征可能有助于识别腹泻型肠易激综合征,一种与应激相关的疾病。

相似文献

[1]
Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

Gut. 2007-2

[2]
Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.

Gut. 2012-5-25

[3]
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.

Am J Gastroenterol. 2011-3-22

[4]
Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.

Gut. 2014-9-10

[5]
Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.

J Gastroenterol Hepatol. 2006-1

[6]
Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.

Scand J Gastroenterol. 2014-1

[7]
The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.

J Gastroenterol Hepatol. 2008-11

[8]
Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.

Gut. 2008-4

[9]
Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?

Am J Gastroenterol. 2012-4-10

[10]
The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.

Am J Gastroenterol. 2012-3-13

引用本文的文献

[1]
Diarrhea-predominant irritable bowel syndrome as a masquerade for systemic mastocytosis: review article and illustrating case report.

Arch Med Sci. 2024-4-25

[2]
Mast cell modulation: A novel therapeutic strategy for abdominal pain in irritable bowel syndrome.

Cell Rep Med. 2024-10-15

[3]
A New Strategy for Dietary Nutrition to Improve Intestinal Homeostasis in Diarrheal Irritable Bowel Syndrome: A Perspective on Intestinal Flora and Intestinal Epithelial Interaction.

Nutrients. 2024-9-21

[4]
The PDIA3-STAT3 protein complex regulates IBS formation and development via CTSS/MHC-II pathway-mediated intestinal inflammation.

Heliyon. 2024-8-28

[5]
Evidence-Based Clinical Guidelines for Chronic Diarrhea 2023.

Digestion. 2024

[6]
and irritable bowel syndrome.

Trop Parasitol. 2024

[7]
The alteration of mucosal bile acid profile is associated with nerve growth factor expression in mast cells and bowel symptoms in diarrhea-predominant irritable bowel syndrome.

Clin Exp Immunol. 2024-4-23

[8]
Global trends in research related to functional dyspepsia and anxiety or depression over the past two decades: a bibliometric analysis.

Front Neurosci. 2023-11-2

[9]
Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships.

Gut Microbes. 2023-12

[10]
Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice.

Nat Microbiol. 2023-10

本文引用的文献

[1]
Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea.

Arch Pathol Lab Med. 2006-3

[2]
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?

Gastroenterology. 2006-2

[3]
Functional gastrointestinal disorders and mast cells: implications for therapy.

Neurogastroenterol Motil. 2006-1

[4]
Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway.

Mol Pharmacol. 2006-3

[5]
Chronic urticaria is associated with mast cell infiltration in the gastroduodenal mucosa.

Virchows Arch. 2006-3

[6]
Mast cell tryptase controls paracellular permeability of the intestine. Role of protease-activated receptor 2 and beta-arrestins.

J Biol Chem. 2005-9-9

[7]
Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor beta1.

Gut. 2005-7

[8]
Psychiatric and psychological dysfunction in irritable bowel syndrome and the role of psychological treatments.

Gastroenterol Clin North Am. 2005-6

[9]
Is irritable bowel syndrome a low-grade inflammatory bowel disease?

Gastroenterol Clin North Am. 2005-6

[10]
Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

Annu Rev Immunol. 2005

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索